How would they fund any further trials though? Without SB revenue only options are CR or partnership, and both would significantly dilute shareholdings I would imagine. Unfortunately I think we’re between a rock and a hard place for a few months.
Bot Chart, page-9385
-
- There are more pages in this discussion • 6,009 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.010(2.90%) |
Mkt cap ! $631.5M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.5¢ | 34.5¢ | $725.5K | 2.076M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 208361 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 136405 | 10 |
View Market Depth
| Last trade - 13.26pm 21/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |